Iambic completed an IPO financing of 150 million USD

Iambic Therapeutics, in which NVIDIA has a stake, completed its initial public offering in the United States, raising $150 million, with an issue price of $16 per share, issuing approximately 9.38 million shares.

The company's market capitalization reached $758 million, and the funds raised will be used to advance three early-stage cancer drugs.